SUGENTECH INC. Funds and ETFs Sugentech Inc.
Equities
A253840
KR7253840003
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,460 KRW | -0.36% |
|
-3.36% | -29.55% |
| 2023 | Tranche Update on Sugentech Inc.'s Equity Buyback Plan announced on March 29, 2023. | CI |
| 2023 | Tranche Update on Sugentech Inc.'s Equity Buyback Plan announced on March 29, 2023. | CI |
Sugentech Incorporate is a Korea-based company mainly engaged in the production and sale of in-vitro diagnostic test reagents. The Company is involved in the manufacturing and sale of in vitro diagnostic test reagents, point-of-care testing (POCT) products, folic acid products under the name of SOLGAR, as well as molecular diagnostic reagents. The in vitro diagnostic test reagents are for personal use and are sold under the name SUREARLY. The POCT products are for professional use and are sold under the name INCLIX. In addition, the Company is engaged in therapeutic drug monitoring, as well as drug analysis method development. The Company distributes its products within the domestic market and to overseas markets, including Indonesia.
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -29.55% | 60.83M | |
| -0.60% | 12.95B | |
| -9.59% | 7.84B | |
| +1.82% | 5.5B | |
| +0.02% | 4.61B | |
| +7.65% | 4.61B | |
| -48.17% | 3.4B | |
| +6.42% | 2.66B | |
| -14.59% | 2.08B | |
| +2.56% | 1.79B |
- Stock Market
- Equities
- A253840 Stock
- Funds and ETFs Sugentech Inc.
